Cardiovascular Risk Assessment and Prevention Across the Life Course: Propensity, Determinants, Risk, Disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Early Life Vascular Risk and Midlife Markers of Brain Aging.Stroke · 2026
   Article
2. Cardiovascular Health Changes in Young Adults and Risk of Later-Life Cardiovascular Disease.JAMA network open · 2025
   Article
3. Management recommendations to reduce cardiac risk in chronic epilepsy.Epilepsy & behavior reports · 2025
   Review
4. Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood.Journal of the American College of Cardiology · 2024
   Article
5. Cardiologists' knowledge and implementation of lifestyle counselling for cardiovascular disease prevention: A national survey.Bioinformation · 2024
   Article
6. Academic Lifestyle Medicine and Physician Education.American journal of lifestyle medicine
   Review

Corrections and comments

• Comment on
  Incidence of Atherosclerotic Cardiovascular Disease in Young Adults at Low Short-Term But High Long-Term Risk.2023

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as